{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:36:01Z","timestamp":1791729361388,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3503,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1093\/annonc\/mdp432","type":"journal-article","created":{"date-parts":[[2009,10,27]],"date-time":"2009-10-27T22:09:46Z","timestamp":1256681386000},"page":"1046-1052","source":"Crossref","is-referenced-by-count":181,"title":["Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy"],"prefix":"10.1016","volume":"21","author":[{"given":"D.","family":"Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.N.","family":"Shenkier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Gascoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.H.","family":"Sehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.J.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1093\/annonc\/mdp432_bb0010","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.hoc.2005.05.003","article-title":"Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma","volume":"19","author":"Bierman","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"10.1093\/annonc\/mdp432_bb0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2004-05-1982","article-title":"High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology","volume":"105","author":"Hegde","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1093\/annonc\/mdp432_bb0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.blre.2006.02.001","article-title":"CNS prophylaxis in lymphoma: who to target and what therapy to use","volume":"20","author":"Hill","year":"2006","journal-title":"Blood Rev"},{"issue":"10","key":"10.1093\/annonc\/mdp432_bb0025","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","article-title":"Adult Burkitt leukemia and lymphoma","volume":"104","author":"Blum","year":"2004","journal-title":"Blood"},{"issue":"19","key":"10.1093\/annonc\/mdp432_bb0030","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma","volume":"24","author":"Habermann","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdp432_bb0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1093\/annonc\/mdp432_bb0040","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","article-title":"Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte","volume":"23","author":"Feugier","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1093\/annonc\/mdp432_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","article-title":"Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)","volume":"9","author":"Pfreundschuh","year":"2008","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1093\/annonc\/mdp432_bb0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdp432_bb0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/annonc\/mdh013","article-title":"Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab","volume":"15","author":"Feugier","year":"2004","journal-title":"Ann Oncol"},{"issue":"17","key":"10.1093\/annonc\/mdp432_bb0060","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1182\/blood-2008-10-182253","article-title":"CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German high-grade non-Hodgkin lymphoma study group (DSHNHL)","volume":"113","author":"Boehme","year":"2009","journal-title":"Blood"},{"issue":"22","key":"10.1093\/annonc\/mdp432_bb0065","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","article-title":"Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia","volume":"23","author":"Sehn","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1093\/annonc\/mdp432_bb0070","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1080\/1042819021000006475","article-title":"Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma","volume":"43","author":"Chua","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1093\/annonc\/mdp432_bb0075","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/annonc\/mdf175","article-title":"Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model","volume":"13","author":"Hollender","year":"2002","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1093\/annonc\/mdp432_bb0080","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1080\/17402520500182345","article-title":"Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis","volume":"46","author":"Laskin","year":"2005","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1093\/annonc\/mdp432_bb0085","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdp432_bb0090","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12185-009-0289-2","article-title":"Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience","volume":"89","author":"Shimazu","year":"2009","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1093\/annonc\/mdp432_bb0095","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2002-06-1636","article-title":"Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment","volume":"101","author":"Rubenstein","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1093\/annonc\/mdp432_bb0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1008260120532","article-title":"For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group","volume":"9","author":"Bos","year":"1998","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdp432_bb0105","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V91.4.1178","article-title":"Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma","volume":"91","author":"van Besien","year":"1998","journal-title":"Blood"},{"issue":"6","key":"10.1093\/annonc\/mdp432_bb0110","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/A:1008394827806","volume":"11","author":"Haioun","year":"2000","journal-title":"Ann Oncol"},{"issue":"3\u20134","key":"10.1093\/annonc\/mdp432_bb0115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/10428190009087024","article-title":"Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations","volume":"38","author":"Tomita","year":"2000","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1093\/annonc\/mdp432_bb0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00277-005-1096-3","article-title":"Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system","volume":"85","author":"Jahnke","year":"2006","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1093\/annonc\/mdp432_bb0125","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/annonc\/mdm073","article-title":"Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up","volume":"18","author":"Bjorkholm","year":"2007","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdp432_bb0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/annonc\/mdl327","article-title":"Incidence and risk factors of central nervous system recurrence in aggressive lymphoma\u2014a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)","volume":"18","author":"Boehme","year":"2007","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdp432_bb0135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2008.16.8021","article-title":"Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516\u2014the Southwest Oncology Group","volume":"27","author":"Bernstein","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419392154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419392154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/5\/1046\/648039\/mdp432.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T03:22:20Z","timestamp":1624504940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419392154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0923753419392154"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdp432","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}